Advanced searches left 3/3

Cardiovascular Disease in Australia - Europe PMC

Summarized by Plex Scholar
Last Updated: 02 July 2022

* If you want to update the article please login/register

Predicted cardiovascular disease risk and prescribing of antihypertensive therapy among patients with hypertension in Australia using MedicineInsight.

Hypertension guidelines recommend that absolute cardiovascular disease risk factor governing the care of hypertensive patients. This study was designed to determine the percentage of patients with diagnosed hypertension with sufficient information to determine absolute CVD risk and determine whether CVD risk is related to prescribing antihypertensive medications. Patients with hypertension [50. 6 percent ] were more likely for patients with chronic medical evidence available to estimate CVD risk than for patients without a diagnosis of hypertension [38. 7%]. 29. 3% of patients with sufficient information to determine CVD danger were at high risk clinically, 6. 0% were at high risk of cardiovascular disease, 12. 8% at moderate risk, and 50. 8 percent at low risk. Precribing was marginally lower in patients at high risk based on their CVD risk score [57. 4% ] or moderate risk [61. 9% ] or at high risk clinically [64. 1% ] or at high risk [64. 1% ] or at high risk clinically [64. 9% ].

Source link: https://europepmc.org/article/MED/35501358


Future burden of cardiovascular disease in Australia: impact on health and economic outcomes between 2020 and 2029.

Aims To estimate the health and economic costs of new and established cardiovascular disease in Australia from 2020 to 2029. Using Australian demographic data and the Pooled Cohort Equation, a primary prevention population was determined. The REACH registry contained a risk for the secondary prevention population. By 2029, 1 611 756 Australians will have common cardiovascular disease by 2029. 5 876 975 QALYs The population lived with 8 815 271 [95% uncertainty interval 8 805 023-8410] years of life, from 8 815 271 [95% uncertainty interval 8 805 083-842] years. CVD's total healthcare expenses were expected to exceed Australian dollars 61. 89 billion, with productivity losses accounting for AUD 78. 75 billion, bringing the total bill to more than AUD 140. 65 billion. Conclusion Cardiovascular disease in Australia has major implications on morbidity, mortality, and estimated expenditures to the healthcare system and the community.

Source link: https://europepmc.org/article/MED/33686414

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions